share_log

Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure

Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure

觀看 CytoSorbents;Hearing Zacks Small-Cap Research 設定了 6 美元的目標股價;CytoSorbents 公佈了 2023 年第二季度的財務和經營業績,顯示產品收入強勁增長,成本結構有所改善
Benzinga ·  2023/08/03 13:14

Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure

觀看 CytoSorbents;Hearing Zacks Small-Cap Research 設定了 6 美元的目標股價;CytoSorbents 公佈了 2023 年第二季度的財務和經營業績,顯示產品收入強勁增長,成本結構有所改善

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論